MX2009001200A - Uso antiviral de un tensoactivo cationico. - Google Patents
Uso antiviral de un tensoactivo cationico.Info
- Publication number
- MX2009001200A MX2009001200A MX2009001200A MX2009001200A MX2009001200A MX 2009001200 A MX2009001200 A MX 2009001200A MX 2009001200 A MX2009001200 A MX 2009001200A MX 2009001200 A MX2009001200 A MX 2009001200A MX 2009001200 A MX2009001200 A MX 2009001200A
- Authority
- MX
- Mexico
- Prior art keywords
- virus
- lae
- cultures
- cationic surfactants
- type
- Prior art date
Links
- 239000003093 cationic surfactant Substances 0.000 title abstract 3
- 230000000840 anti-viral effect Effects 0.000 title 1
- 241000700605 Viruses Species 0.000 abstract 2
- ILRSCQWREDREME-UHFFFAOYSA-N dodecanamide Chemical compound CCCCCCCCCCCC(N)=O ILRSCQWREDREME-UHFFFAOYSA-N 0.000 abstract 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 abstract 2
- 239000004475 Arginine Substances 0.000 abstract 1
- KWTQSFXGGICVPE-WCCKRBBISA-N Arginine hydrochloride Chemical compound Cl.OC(=O)[C@@H](N)CCCN=C(N)N KWTQSFXGGICVPE-WCCKRBBISA-N 0.000 abstract 1
- 241000283690 Bos taurus Species 0.000 abstract 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 abstract 1
- 239000005639 Lauric acid Substances 0.000 abstract 1
- 241000700618 Vaccinia virus Species 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 1
- 230000005494 condensation Effects 0.000 abstract 1
- 238000009833 condensation Methods 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 125000004494 ethyl ester group Chemical group 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 229940116335 lauramide Drugs 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 241001529453 unidentified herpesvirus Species 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Los tensoactivos catiónicos derivados de la condensación de ácidos grasos y aminoácidos dibásicos eterificados, tal como el proveniente del ácido laúrico y la arginina, en particular el éster etílico de la lauramida del monohidrocloruro de la arginina (LAE), puede ser usado para la protección contra el crecimiento de microorganismos; los tensoactivos catiónicos de este tipo son también efectivos contra las infecciones virales; el añadido de LAE a cultivos de Herpes virus tipo 1, virus de Vaccinia y virus de la parainfluenza bovina 3 conduce a una reducción completa en una etapa temprana de los organismos virales en dichos cultivos, tales efectos comienzan a ser observados luego de 5 y 60 minutos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2006/065035 WO2008014824A1 (en) | 2006-08-03 | 2006-08-03 | Antiviral use of cationic surfactant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009001200A true MX2009001200A (es) | 2009-02-11 |
Family
ID=37728271
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009001200A MX2009001200A (es) | 2006-08-03 | 2006-08-03 | Uso antiviral de un tensoactivo cationico. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP2046316B1 (es) |
| JP (1) | JP2009545541A (es) |
| CN (1) | CN101500552A (es) |
| AR (1) | AR061309A1 (es) |
| AT (1) | ATE482697T1 (es) |
| AU (1) | AU2006346933A1 (es) |
| BR (1) | BRPI0621922A2 (es) |
| CA (1) | CA2658446A1 (es) |
| DE (1) | DE602006017272D1 (es) |
| ES (1) | ES2353726T3 (es) |
| IL (1) | IL196583A0 (es) |
| MX (1) | MX2009001200A (es) |
| WO (1) | WO2008014824A1 (es) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8926997B1 (en) | 2003-02-06 | 2015-01-06 | Richard F. Stockel | Polymeric biocidal salts |
| US8795638B1 (en) | 2003-08-26 | 2014-08-05 | Nevada Naturals Inc. | Compositions for dental care |
| US8193244B1 (en) | 2008-05-29 | 2012-06-05 | Nevada Naturals, Inc. | Antimicrobial agents |
| US9023891B2 (en) | 2008-05-29 | 2015-05-05 | Nevada Naturals, Inc. | Synergistic antimicrobial agents |
| BRPI0913835A2 (pt) | 2008-07-02 | 2016-08-09 | Miret Lab | uso de tensoativos catiônicos como agentes esporicidas |
| CH701769A1 (de) | 2009-09-08 | 2011-03-15 | Schoeller Textil Ag | Wiederbeladbare Ausrüstungen für Textilien und Formulierungen zur Beladung solcher Ausrüstungen. |
| ES2544284T3 (es) | 2010-02-26 | 2015-08-28 | Ajinomoto Co., Inc. | Composición que inactiva virus que contiene un compuesto de bajo peso molecular y arginina |
| US8834857B1 (en) | 2011-01-18 | 2014-09-16 | Nevada Naturals Inc. | Deodorizing and skin cleaning |
| WO2013103556A1 (en) * | 2012-01-05 | 2013-07-11 | The Trustees Of Columbia University In The City Of New York | Antimicrobial composition |
| EP3474838A1 (en) * | 2016-06-28 | 2019-05-01 | Pisak, Mehmet Nevzat | Surfactants for treatment of skin infections caused by double stranded dna viruses of the herpesviridae or papillomaviridae families |
| CN108740356B (zh) * | 2017-11-03 | 2022-10-25 | 华东师范大学 | 月桂酰精氨酸乙酯衍生物作为饲料添加剂的用途 |
| CN108935967A (zh) * | 2017-11-03 | 2018-12-07 | 华东师范大学 | 月桂酰精氨酸乙酯作为饲料营养能量物质的用途 |
| CN113797189A (zh) * | 2017-11-03 | 2021-12-17 | 华东师范大学 | 月桂酰精氨酸乙酯衍生物和作为动物用抗菌剂的用途 |
| CN110302192A (zh) * | 2018-06-22 | 2019-10-08 | 华东师范大学 | 新的抗微生物组合物及其制备方法和应用 |
| CN112889835B (zh) * | 2018-06-22 | 2022-06-07 | 华东师范大学 | 新的食品防腐剂及其制备方法和应用 |
| CN110314107A (zh) * | 2018-06-22 | 2019-10-11 | 华东师范大学 | 新的口腔护理组合物及其制备方法和应用 |
| CN112790197B (zh) * | 2018-06-22 | 2022-06-21 | 华东师范大学 | 新型皮革防霉护理剂及其制备方法和应用 |
| CN110313488B (zh) * | 2018-06-22 | 2021-07-27 | 华东师范大学 | 防霉型粘合剂及其制备方法和应用 |
| CN110317684B (zh) * | 2018-06-22 | 2021-05-25 | 华东师范大学 | 天然环保无毒的厨房油污清洗剂 |
| CN112790196B (zh) * | 2018-06-22 | 2022-05-06 | 华东师范大学 | 防腐杀菌型湿巾及其制备方法和应用 |
| CN110314108A (zh) * | 2018-06-22 | 2019-10-11 | 华东师范大学 | 新的洗浴用品组合物及其制备方法和应用 |
| CN112107566A (zh) * | 2019-06-21 | 2020-12-22 | 华东师范大学 | 月桂酰精氨酸乙酯及其衍生物作为抗病毒剂的用途 |
| US12186335B2 (en) * | 2020-04-23 | 2025-01-07 | Johnson & Johnson Consumer Inc. | Methods and compositions for inhibiting enveloped viruses using high molecular weight hydrophobically modified alkali swellable emulsion polymers and surfactant |
| KR20220054586A (ko) * | 2020-08-31 | 2022-05-03 | 샐바시온 유에스에이 인크. | 항바이러스 조성물 |
| US12226731B2 (en) | 2020-09-04 | 2025-02-18 | G.H.L. International, Inc. | Infectious agent air treatment system, apparatus, and method |
| US20230151302A1 (en) | 2020-12-08 | 2023-05-18 | Laboratorios Miret, S.A. | Cationic surfactants, in particular ethyl lauroyl arginate LAE, for treating or preventing infections and contaminations with Coronavirus |
| CN114681628A (zh) * | 2022-01-24 | 2022-07-01 | 抚顺东科新能源科技有限公司 | 一种温和无刺激医用超声凝胶及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53118516A (en) * | 1977-03-24 | 1978-10-17 | Ajinomoto Co Inc | Inactivation disinfectant of hepatitis-b virus |
| JPS5645402A (en) * | 1979-09-21 | 1981-04-25 | Ajinomoto Co Inc | Disinfectant inactivating hepatitis virus b |
| MXPA04001168A (es) * | 2001-08-09 | 2005-02-17 | Miret Lab | Uso de agentes tensioactivos cationicos en preparaciones cosmeticas. |
| MXPA04003855A (es) * | 2001-10-25 | 2004-07-08 | Miret Lab | Uso de consevadores cationicos en productos alimenticios. |
| EP2082724B1 (en) * | 2001-11-15 | 2013-08-21 | Laboratorios Miret, S.A. | Use of cationic surfactant as antimicrobial activity enhancer in deodorants and oral care |
| US20060264347A1 (en) * | 2005-05-19 | 2006-11-23 | Xintian Ming | Antimicrobial composition |
-
2006
- 2006-08-03 BR BRPI0621922-5A patent/BRPI0621922A2/pt not_active IP Right Cessation
- 2006-08-03 MX MX2009001200A patent/MX2009001200A/es active IP Right Grant
- 2006-08-03 AT AT06792670T patent/ATE482697T1/de not_active IP Right Cessation
- 2006-08-03 WO PCT/EP2006/065035 patent/WO2008014824A1/en not_active Ceased
- 2006-08-03 JP JP2009522106A patent/JP2009545541A/ja active Pending
- 2006-08-03 DE DE602006017272T patent/DE602006017272D1/de active Active
- 2006-08-03 AU AU2006346933A patent/AU2006346933A1/en not_active Abandoned
- 2006-08-03 CA CA002658446A patent/CA2658446A1/en not_active Abandoned
- 2006-08-03 CN CNA2006800555193A patent/CN101500552A/zh active Pending
- 2006-08-03 EP EP06792670A patent/EP2046316B1/en not_active Revoked
- 2006-08-03 ES ES06792670T patent/ES2353726T3/es active Active
-
2007
- 2007-06-08 AR ARP070102512A patent/AR061309A1/es not_active Application Discontinuation
-
2009
- 2009-01-19 IL IL196583A patent/IL196583A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009545541A (ja) | 2009-12-24 |
| EP2046316A1 (en) | 2009-04-15 |
| ES2353726T3 (es) | 2011-03-04 |
| BRPI0621922A2 (pt) | 2011-12-20 |
| IL196583A0 (en) | 2009-11-18 |
| CN101500552A (zh) | 2009-08-05 |
| CA2658446A1 (en) | 2008-02-07 |
| AR061309A1 (es) | 2008-08-20 |
| AU2006346933A1 (en) | 2008-02-07 |
| EP2046316B1 (en) | 2010-09-29 |
| DE602006017272D1 (de) | 2010-11-11 |
| WO2008014824A1 (en) | 2008-02-07 |
| ATE482697T1 (de) | 2010-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009001200A (es) | Uso antiviral de un tensoactivo cationico. | |
| UY30485A1 (es) | Uso antiviral de un tensioactivo cationico | |
| WO2010051541A3 (en) | Compositions containing delta-9-thc-amino acid esters and process of preparation | |
| BR0114147A (pt) | Uso de tensoativos catiÈnicos em preparações cosméticas | |
| NO20071369L (no) | Antimikrobiske peptider omfattende et arginin- og/eller lysin-inneholdende motiv | |
| TNSN01108A1 (en) | Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids | |
| BR0112420A (pt) | Composto, composição farmacêutica, uso de um composto, e, método para produzir um efeito inibidor de ciclo celular (anti-proliferação celular) em um animal de sangue quente | |
| MXPA05008172A (es) | Derivados de malonamida como inhibidores gamma-secretasa. | |
| NZ603232A (en) | Nucleoside phosphoramidates | |
| TW200724134A (en) | Antimicrobial compositions and methods | |
| TN2011000346A1 (en) | Benzoic acid (1-phenyl-2-pyridin-4-yl)ethyl esters as phosphodiesterase inhibitors | |
| TW200716589A (en) | Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]-oxepino [4,5-c] pyrrole | |
| MY165152A (en) | Cyclosporine analogue molecules modified at amino acid 1 and 3 | |
| WO2011133463A3 (en) | Antimicrobial compositions comprising organic acid esters and methods for reducing virus and bacterial populations using such compositions | |
| MX2011012334A (es) | Composicion y metodo para promover el crecimiento de raices de plantas. | |
| AR047513A1 (es) | Metodos y composiciones para el tratamiento de cambios en la piel relacionados con el envejecimiento y los danos ocasionados por el medio ambiente | |
| MX2009012742A (es) | Ingrediente activo novedoso en cicatrizacion y uso del mismo. | |
| MY166631A (en) | Orally administrable composition for improving skin quality | |
| SG179406A1 (en) | Lyophilized preparation comprising influenza vaccine, and method for preparation thereof | |
| BR0215303A (pt) | Formulações farmacêuticas de base aquosa de pró-drogas solúveis em água de propofol | |
| ES2422593T3 (es) | Método y uso de una composición para lavavajillas | |
| WO2012037498A3 (en) | Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo | |
| WO2006125121A3 (en) | Antimicrobial composition comprising a cationic surfacant and an iodinated sulpone compound | |
| WO2011133963A3 (en) | Tyrosine-based prodrugs of antiviral agents | |
| DE60104695D1 (de) | Zusammensetzungen aus aminosäuren zur behandlung von herzinsuffizienz |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |